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1 .. 
INTRODUCTION 
In the past few years the condition known 
as agranulocytosis hE-s apparently bc;cc,II!e much 
more common, both in this country and abroad. 
Its dramatic symptons and signs, together with 
its high mortality rate, have brought the dis-
ease into sharp relief and have resulted in oc-
casional expression of clear cut opinions as to 
its etiology, p2tthology, and treatment which are 
not, in all instances, entirely justified. In 
spite of our recently acquired familiarity with 
the disease, it still remains a mystery in many 
respects. 
Certain ruchors, Rose and Houser (1), Brog-
sitter and Von Kress (2), Zikowsky (3), Aubertin 
and Levy (4), regard the disease not as a clin-
ical entity but rath,;r as a syndrome common to 
many pathological conditions and their view may 
yet be proved correct. Befc)re this question can 
be definitely answered a large number of cases 
must be carefully studied both from a clinical 
and a pathological point of view. 
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Rose and Houser (1) give a number of argu-
ments in support of their belief that agran-
ulocytosis is not a specific entity and their 
reasoning is similar to that of many authors 
who hold the same view. Leukopenia occurs, 
they say, under many conditions. Yet the fact 
that anemia occurs under many circumstances 
does not militate against the fact that per-
nicious anemia is an entity. They point out 
that there is no knov-n etiological agent for 
agranulocytosis and that the condition has not 
been exactly reproduced in animals; yet it does 
not follow from these facts that there is no 
such disease. The etiology of myelogenous leu-
kemia is unknown, nor has it been exactly pro-
duced in animals. Consequently I do not be-
lievesuch arguments can so easily dispose of 
such a difficult question. 
That extreme leukopenia and neutropenia 
alone does not constitute valid criteria for 
the establishment of a single disease should 
be obvious. Several authors, Brogsitter and 
Von Kress (2), Blumer (5), Pepp(~r (6), Jackson 
(7), and Doan (8), have pointed out that 
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hematological pictures similar to that seen in 
agranulocytosis may be found in many diverse 
conditions, Yet because one disease may easily 
be confused with others does not argue that the 
first is not an entity. 
Brogsitter (2), in a consideration of agran-
ulocytosis, lists thirty-four patients with marked 
leukopenia and grEnulopenia in which the hematol-
ogical picture was directly traceable to some 
other underlying cause. However, in this series 
of cases, fifty percent were males and in this 
fifty percent there ~ere nineteen with noticeable 
anemia and in seventy-eight percent of the cases 
the platelets were markedly diminished. These 
are not characteristic findings of true agran-
ulocytosis. Doan (8) believes that only twenty 
percent of the cases referred to his clinic with 
leukopenia could be regarded as falling into the 
narrow classification of true agranulocytosis, 
while Metteir (9) in a study of 1167 cases of 
leukopenia, found on:j.y six perc -'nt in which the 
cases were not explainable on the basis of some 
well recognized disease, of which the leukopenia 
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was but one striking sign. Moderate leukopenia 
is seen in the course of many infections; ex-
treme; l";ukopenia may occur as a sequel to over 
whelming sepsis; it is seen as a result of Ben-
zol poisoning and may be due to the toxic af-
fect of gold, bismuth or arsenic; it is a prom-
inent feature in aplastic anemia; it is not 
uncommon in severe pernicious anemia and is oc-
casionally seen in both acute and chronic leu-
kemia. There is no doubt but that the majority 
of patients with leukopenia have some well rec-
ognized fundamental disorder to account for this 
hematological abnormality and furth·c;r that this 
disorder is" in some instances unrelated, primar-
ily to the hematopoetic system. Lack of apprec -
iation of these undoubted facts necessarily leads 
to false thinking as regards the etiology, path-
ology, and treatment of the disease or syndrome, 
agranulocytosis. 
Acute leukemia in the aleukemic phase very 
closely simulGtes agranulocytosis and the two 
diseases are not infrequently mistaken one for" 
the other, (10), (11), (12). In fact, at the 
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present, the re..;.stionship of the two conditions 
must be regarded as problematical. Yet there 
would appear to be certain essential differences. 
Absence or marked dim±nution of platelets, anemia 
of moment, particularly if progressive, hemorrhages, 
especiall.v from the mucous membrC'nes of the mouth 
notable enlargement of the spleen and enlargement 
of lymph nodes, not readily explainable by ad-
jacent ulceration and infection, all indicate acute 
leukemia. In acute leukemia, especially in adults, 
the blood smear shows a considerable number of very 
immature cells; often virtually all the while blood 
cells are stem cells [,nd it is only in the most 
atypical cases that young forms are few in number, 
an occasional stem cell may be found in the blood 
of pc,tients suffering from agranulocyt sis. Any 
very considerable number, however, indicates the 
probability of a leukemia and the more there are 
the ~reater the probability_ A level is reached, 
which is more than tem?orary, almost certainly 
means leukemia. DUring convalescence from agran-
ulocytosis there may be, and in fact usually is, 
a transient outpouring of myelocytes, but this 
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stage is soon passed and clinical improvement 
is coincidentally evident. 
Leukemic patients with temperatu:':'es of 
102 degrees to 104 degrees F may seem compar-
atively well. This is rarely the case in agran-
ulocytosis. In this latter disease such tem-
peratures are almost invariably accompanied by 
marked prostration and symptoms of toxicity. 
In agranulocytosis, the fever is either steady 
or, more commonly, fluctuates within certain 
defini te rather rather limits. In cccute leu-
kemia the temperature curve if often an ex-
tremel¥ variable one. Afebrile periods are 
not rare, even at the height of the disease. 
It must be emphasized that the total white is 
of no vital importance in the diagnosis of 
leukemia '."h:"ther the ',o,hi te count be 500 or 
50,000 per c.mm. The character of the white 
cells, the concomitant alterations in the 
red cells, and platelet picture and the path-
ological changes in the bone marrow determine 
the diagnosis and serve, at least in the maj-
7. 
qrity of instances, to mark the one from the 
other disease. Acute leukemia, furthermore, 
is the more likely the younger the patient 
and it is probable that the majority of the 
extreme leukopenias in children are trace-
able to leukemia or to some serious disorder 
of the myeloid system other than true agran-
ulocytosis. 
Those cases showing very low red cell 
counts depart more obviously from true agran-
ulocytosis. The lower the red cell count the 
less likely the disease is to be true agran-
ulocytosis. With marked anemia, pancytopenia 
or pernicious [J.nemia with an unusually low \'lhi te 
cell count is the more likely the diagnosis, 
but in certain instances the white cells in the 
peripheral blood of patients with pancytopenia 
fall far more rapidly and to a much greater ex-
tent than do the other formed elements and if 
sepsis should ensue one may have as in a case 
cited by Jackson and Parker (13) a ~cture more 
closely resembling true agranulocytosis. 
8. 
However, this condition can be distinguished 
as a rule from agranulocytosis by the paucity 
of platelets, the progressive anemia, the pre-
sence of at least a few neutrophils in the per-
ipheral blood and a tendency to bleeding from 
the mucous membranes. Yet, as with aleukemic 
leukemia, there may arise great difficulties 
as it is well within the realms of possibility 
that one disease may shede into the other. 
Bearing in mind these diagnostic and nos-
ological difficulties it does seem, however, 
that, aft~r discarding the extreme leukopenias 
secondary to sepii" a leukemic leukemia, a 
plastic cmemia, pancytopenia and leukopnias 
of certain metastatic bone tumors, a senic, gold 
and benzol poisoning, there remains what for lack 
of a better term may be called agranulocytosis, 
agranulocytic angina or idiopathic malignant 
neutropenia.. It is of this condition that I will 
discuss as to its etiology, pathology and treatment. 
9. 
ETIOLOGY 
The majority or the earlier authors re-
garded agranulocytosis as a direct result of 
overwhelming infection,Brogsitter (2). Yet 
geadually this point or .view has been chang-
ing and there would seem to be considerable 
evidenee that sepsis is not the cause, but 
rather the result of the disease. That such 
is the case is atestedto by the fact that 
the white count has been found by many auth.;"o 
ors to be lowered ror several days before any 
clinical signs or symptoms have been man1rest. 
In a case or Jackson and Parker (13) the white 
count was 500 per c.mm. or lower for four days 
berore the appearance of any clinical signs or;i 
symptoms whatsaver. On the rifth day the pat-
ient had an abrupt rise of temperature to 104 
degrees F., chills, headache, prostration and 
severe sore throat. Bacteria has succesfully 
invaded a defenseless organism. I believe it 
is difficult to invision an infection so potent 
as to virtually abolosh lwukopoiesis without 
-10. 
at the same time giving rise to some other outward 
and visible sign or symptom. It is more logical 
to assume that the depletion of the available leu-
koeytes renders the organizm liable to infection 
of a most virulent sort. This belief~has been 
frequently expressed (6), (7), ,(8), (11), (14), 
and (16). Furthermore, in those instances in 
which infection appears to be the true cause of 
the leukopenia, the differential white count and 
histological picture in the bone marrow are quite 
different from that seen in agranulocytosis. In 
overwhelming sepsis the total perepheral white 
count may indeed be very low but polymorphonuclear 
neutrophils usually form a large percentage of 
the remaining cells. Myelocites and young polys 
are common, even at the height of the leukopenia. 
In the unusually active bone marrow all stages 
of myelopoiesis are seen. Such a pathological 
picture is never seen in agranulocytosis wbBn 
the disease is at its height. In this condit-
ion,the neutrophils virtually disappear from 
the pertpheral., blood and in the bone marrow 
no forms more mature than stem cells, or at 
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best promyelocytes, are seen unless there has 
already been blood regeneration and the pat-
ient has died of some complication, as is oc-
casionally the case. These pathological changes 
will be discussed in detail later. 
Overwhelming infection can in all probab-
ility be discarded as a common cause of true 
agranulocytosis. 
Pepper (6) has suggested allergy to be of 
etblogical importance in the production of agran-
ulocytosis. However, little has been written 
to substantiate his suggestion. 
Jackson, Merrill, and Duane (17) and also 
Thompson (18) have suggested that some endocrine 
disturbance is the basis fur tae condition by the 
fact that in many instances the disease occurs 
at the time of menstruation. Thayer and Hansen-
Pruss (19) reported a case in which attacks oc-
cuned regularly for over twenty years at ap-
proximately twenty~five day intervals. This 
case would seem almost certainly to be of 
glandular origin. It is doubtful, however, 
12. 
whether any very large percentage of the cases 
may be definitely traced to an endocrine dis-
turbance. Thayer~ patient appears to be unique 
and the fact that many female patients suffer 
from remissions or attacks at the onset of 
their catamenias dOGS not necessarilly lay any 
very solid foundation for an endocrine etiology 
of the disease. 
~he fact that agranulocytosis has increased 
markedly in recent years together with the known 
leukotoxic effect of the benzene ring, makes most 
tempting the theory that some, if not all, cases 
are due to the administ'ration of emidopyrine and 
allied drugs, therapeutic agents which have lately 
become more and more widely used. Madison and 
Squier (20) draw the following conclusions from 
fourteen cases cited in their recent article. 
First, the increase in incidents primary granulo-
cytopenia has paralleled the increase in the use 
of drugs containing amidopyrine and espeCially 
those containing amidopyrin~ with a barbiturate. 
Second, the disease has appeared most frequently 
in persons apt to be taking drugs: physiCians, 
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nurses, and those directly under the care of a 
physician. Third, in each of fourteen patients 
the onset of primary granulocytopenia was dir-
ectly preceded by the use of amldopyrine alone 
or in combination with a barbiturate. Fourth, 
the mortality in a group of six patients who 
continued the use of drugs cuntaining amidopyrine 
was 100 percent. In a group of eight patients 
who did not c~ntinue the use of the drugs, only 
two died, and both died of the initial attack. 
Fifth, the administration of a single dose of 
amidopyrine to each of two patients who had re-
covered from the acute disease was followed by 
a rapid fall in granulocytes. Hoffman, Butt 
and Hickey (21), Watkins (22) and others have 
dravlln attention to a similar relationship be-
tween the drugs and the disease. Seeman ~23) 
however, noted that in thirteen of twenty-six 
cases amidopyrine or its allies had been taken, 
yet in fifteen there was definitely no history 
of such therapy. Similarly Jackson (24) in an 
analysis of twenty-seven of their cases in 
which complete and unequivocal data relative 
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to medication were at hand, found that in only 
seven of them could the disease be properly re-
garded. as directly traceable to the adminis-
tration of the compounds. There can be no 
question but that amidopyrine or its allies 
are of etiological importance, particularly as 
Madison and Squier (20) have produced with these 
drugs mild and transient, but definite granulo-
penia in patients who had recovered from a clas-
sical attack. But there is also no question 
but that in many other instances tt~€is no such 
explanation of the cause of the disease. Further-
more; it has been pointed out that the drug may 
be taken in considerable amounts prior to the on-
set of the disease. Yet on careful analysis it 
may appear that it is of no etiological import-
ance whatsoever.. Eight of twenty-seven cases 
studied by Jackson (2~) had taken amidopyrine 
or allied compounds in considerable quantities, 
yet it could be shown in these instances that 
the therapy had not the slightest causal re-
lation to the actual disease. Therefore, it 
is safe to say that the etiological importance 
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of these drugs is undeniable, but they certainly 
are not the sole cause of the disease. A spec-
ial rel,;ort of the Council on Pharmacy and Chem-
istry of ~he A~erican M~dical Association (25) 
concludes that 'there is, Tlno question that ami-
dopyrine is very important in the production of 
granulocytopenia". The report does not say, 
nor does.oi t imply, that all cases are due to the 
drugs, nor do"es it preclude the possibility 
that there may be some pre-existing bone mar-
row dyscrasia which affords a fulcrum upon which 
the drug may work. 
In a similar manner dinitrophenol has been 
shown to be the apparent cause of the disease 
in certain instances. Bohn (26), Davidson (27), 
Dameshek (28) and Silver (29) hqve substantiated 
this belief. This drug must therefore also be 
regarded as potentially dangerous, even in ther-
apeutic doses. A familial tendency is rarely 
seen. In the articles that I have reviewed, 
I could find no suggestion in the histories of 
cases that would suggest familial tendencies. 
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Th€,refore, when all is summed up, it 
must be oonfessed that the etiology of this 
disease still remains, in large part at least, 
obscure. That some cases appear to be caused 
by the administration of certain chemicals or 
by th-c 3ction of certain toxins should not be 
regarded as indicating that the disease is but 
a syndrone. Pernicious anemia may be due to 
lack of an intrinsic factor, to radical sur-
gical -interference with the gastrc-intestinal 
tract or t9 malignant disease preventing the 
proper functioning of such factors as cause 
a proper maturation of the red cells. In 
a similar manner a variety of agents, known 
and unknov:n, may prevent proper maturation of 
the granular white cells and so produce the 
disease, agranulocytosis. 
-. 
.-
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PATHOLOGY 
The pathology of this disease is in dis-
pute. Much of this confusion arises from fail-
ure on the part of many even to attempt the dif-
ferentiation, either clinically or pathologically, 
of the various conditions giving rise to the strik-
ing but far fvom pathoneumonic s~gn, that of ex-
treme granulopenia.· Ccnfusion also arises from 
too great reliance being placed on the inter-
pretation of stained smears taken from the bone 
marrow. Such smears are of importance in iden-
tifying certain cetls not easily recognized in 
sections sta~ned with eosin-methylene-blue. But 
from smears of bone marrow one gets absolutely 
nO.idea of the number or~rangement of the cells 
and upon such factors, as well as upon the nature 
of the individual cells, the diagnosis of any mar-
row lesion is based. Custer (30) and Peabody (31) 
have ex~ressed this opinion. Roberts and Kracke 
(16) say, "there is an unanimity of opinion that 
the essential pathology is a marked hypoplasia of 
the myelo~ytic tissu~s". In one of their cases 
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sternal puncture (smears) showed a marrow en-
tirely devoid of granular cells of any type, 
including even myeloblasts. In the photomi-
crograph illustrating this feature one would 
be at a loss to, identify any cell according 
to one author. Dodd and Wilkinson (32) state 
that the bone marrow is aplastic, but it should 
be pointed out that they describe the marrow 
of a colored girl of eleven years with hered-
itary syphilis who af'ter treatment with sulph-
arsphenamine developed extreme leukopenia. The 
condttion can hardly be regarded as one of true 
idbpa tl~ic agranulocytos1s • Schultz, who orig-
inally described this disease entity, is of'ten 
quoted as belie.ving the marrow to be ap+astic. 
Yet Leon (33), who described the marrow in 
Schultz's cases, merely says that there were 
neither mature neutrophils nor myelocytes to 
be f'ound and that the femur was partly red, 
partly f'atty. Such s~atements can not be con-
strued as indicating that the author considered 
the·marrow "aplastic". In other instances when 
19. 
the marrow is said to be aplastic, examination 
of the original sources discloses the fact that 
in the case under consideration the tibia or 
midfemur was examined. It is not surprising, 
therefore, that the histological picture of the 
disease is regarded as c:";nfusing. 
Jaffe (34) found the bone marrow rather 
more cellular than normal with signs 6f marked 
degeneration in the granules of the myelocytes. 
These granules were said to "fuse with the cyto-
plasm". Jaffe believed the majority of the white 
cells "to be myelocytes with a moderate or consid-
erable number of plasma cells and lymphocytes. 
Megakaryocytes, he found in normal or in increased 
numbers. Fitz-Hugh and Krumbhaar (35) in a most 
important contribution, postulate a maturation 
arrest at the stem cell stage with the added pos-
sibility of an end stage which might be regarded 
as aplastic. This seems to be the general trend 
of thought. 
Jackson and Parker (52) studied the marrow 
of twenty-five cases which they diagnosed as agran-
ulocytosis. The following generalizations were 
made. The marrow of the ribs, sternum and midfemur 
.-
20. 
and vertebrae was essentially the same. The 
degree of cellularity was usually normal. 
Rarely the femur remained fatty, as ip the nor-
mal adult. It would seem that in these instances 
death occurred too soon for the marrow activity 
to spread per~pherally, although this view is 
not entirely agreed upon. In some sternal and 
vertebral marrows, particularly in patients dy-
ing later in the disease, a certain amount of 
hypoplasia existed. On the other hand in the 
fulminating cases the marrow was perhaps un-
usually rich in cells. The degre~ of cellul-
arity, however, varied but little and is, they 
believe, an unessential feature of the condition. 
There was little or no disturbance in the red 
cell series. E1,'ythroblasts, normoblasts and 
nucleated reds occurred in normal or slightly 
increased numbers and showed no abnormal fea-
tures. The megakaracytes also were found in 
the usual numbers and histologically appeared 
perfectly normal. With this latter finding 
of Jackson and Parker, Rotter (36) and Jaffe 
(34) agree. This seems important since 
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Roberts and Kracke (16) believe that they hem-
orrhagic tendency which they regard as a very 
common sYmp~om to be due to marrow disfunction 
involving megakaryocytes and a decrease bf 
platelet formation~ Most ~~iters have not found 
such a dtscrasia to exist. 
The most marked bone marrcw changes nat-
urally occurr in the cells of the granular ser-
ies. No mature granulocytes, either neutrophils 
or eosinophi1s,are found in the marrow, nor is 
there any true myelocytes. Practically every 
cell that belongs to the granular series is a 
stern cell. The other cells found ar.e plasma 
cells or lymphocytes. That this may be con-
strued as a maturation arrest, Fitz-Hugh and 
Krumbhaar (35), rather than failure to de~iver, 
is evidenced by the fact that the parent cells 
were often inactive mytosis. These stem cells 
seem to be able to produce their own kind of 
profusion. Further maturation is denied. 
Rotter (36) finds that in those patients 
who survive the ravages of infection for a 
considerable period (eight to twenty days) the 
bone marrow picture was somewhat different. 
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It was found to be relatively hypoplastic .. 
Gradua~-ly as the disease progressed, the stem 
cells diminished in number and their place 
was taken by lymphocytes and plasma cells and 
in cases dying as late as the fifteenth day 
after the apparent onset of the disease, the 
cells constituted virtually the only white 
cells in the marrow. This late stage would 
appear to correspond to the terminal "ap+astic" 
stage postulated by Fitz-Hugh and Krumbhaar (35). 
Phagocytic macrophages were at all times present 
in considerable numbers, particularly in the late 
stages of the disease. Such cells have also been 
remarked upon by Jaffe (34). 
It must be recognized that until further 
work is done we cannot speak dogmaticall¥ of the 
patho~ogy of the disease, the nature of which is 
still obscure. At present the view of Fitz-Hugh 
and Krumbhaar regarding a maturation arrest with 
a predominance of lymphocytes and plasma cells 
seems most likely. 
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TREATMENT 
, The treatment of any disease, the path-
ogenesis and nature of which is uncertain, 
is~t best unsatisfactory and the more so when 
that condition ma:r be easily confused with 
other pathological entities of probably a dif-
ferent fundc;.mental nature. Many measures have 
been advocated to combat agranulocytosis. None 
is specific. Most all authori~ies agree that 
the major problem is that of rest9ring the bone 
marrow to its normal activity and thus raising 
the peripheral white count; f"or the loss of leu-
kocytes removes one of the body's great defenses 
against infection. Without bone marrow recovery, 
there can be no cure. 
Non-specific therapy, suchm the injection 
of sterile milk or turpentine, is conceded by al-
most everybody to be useless. ~hat one gets a 
white cell response in normal patients by such 
therapy is not the slightest reason for supposing 
that a similar response should occurr in agran-
ulocytosis. The probable affect of such treat-
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ment in patients with normal bone marrows, is 
chemotactic, that is. the calling force of such 
mature and slightly young :)olys as are readily 
available in the bone marrow, and their rapid 
and efficient replacement. There are no neu-
troph~ls in the bone marrow of a~ranulocytic 
patients to call forth. 
Transufsion of blood has been endorsed 
by some, (1) and (6), and without question re-
coveries have ftilowed one or more such trans-
fusions. Aside from the f&ct that there is 
not good evidence that blood transfusion has 
a stimulating affect in agranulocytosis~ In-
deed, it is not uncommon experience to find 
the peripheral white count definitely lower 
after transfusion than before. The number of 
white cells actually given the patient is 
small; their life short; and further more, the 
patient, as a rule does not need either plasma 
or red cells. In the presence of sepsis, when 
the white count has risen to normal or abnormal-
ly high levels, small multiple tran~sions may 
be of value. There seems to be little convinc-
ing evidence that they ·tend permanently to raise 
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the white count or stimu1"l te the marrow. 
Stimulating doses of X-Ray were advo-
cated by Freidemann and E1ke1es (42). They 
treated forty-three patients. Of these, 
twenty-three either had sepsis or pneumonia 
or died within thirty-:-six hours and all were 
discarded by Fnidemann and Elkeles in eval-
uating the e~cts of roentgen therapy. Of 
the twenty remaining cases there appear to 
be but seventeen individuals and of these 
eight died, a mortality of forty-seven percent. 
It should be recorded for accurate comparison 
of mortality statistics that in the complete 
unexpurgated series the mortality was eighty-
two percent. 
Taussig and Schnoedelen (43) treated 
four cases by X-Ray with a mortality rate of 
fifty percent. Other authors unenthusiastically 
recommend radiation. Reznikoff (44) has expressed 
the opinion that even small doses of X-Ray tend 
to qepress the bone marrow and he points out that 
four or five days must elapse before the effects 
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of any maturant agent can be seen, in the per-
ipheral blood. It is usually claimed by those 
who advocate radiation therapy that hemato-
logical changes of a favorable sort were seen 
in the peripheral blood in a few hours. "fuen 
such changes have occurred, according to Rez-
nikoff (44) it is due to either a re-distrib-
ution phenomena or a spontaneous rise and not 
to genuine stimulation of a dormant or sup:-
pressed marrow. Pepper (6) is not enthusiastic 
about radiation therapy. Dameschek (10) treat-
ed twenty cases with improvement in seven, but 
a year later only two were living, giving a mq~­
tality rate of ninety percent. Therefore, I 
would say that a criti941 analysis of the re-
sults of radiation therapy does not seem to af-
ford any very convincing evidence of its value. 
Roberts and Kracke (16) believe that "sepsis 
and necrosis are the great hope of every patient 
with complete granulopenia". It seems to me that 
this hope is often fulfilled. These same authors, 
however, say that "there is death unless granul-
ocytes reappear". The implication appears to be 
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that sepsis and necrosis in and by themselves 
stimulate the marrow to regeneration and thus 
restore the leukoeytes to the peripheral cir-
cul&tion. It 1s difficult to prove dherwise 
but it certainly seems unlikely. That sepsis 
raises the white count in individuals with a 
normal marrow is no indication that it will do 
so in one whose bone marrow contains as far as 
white cells are concerned, only stem cells. 
Just how sepsis causes leukocytosis and a hyper-
plastic marrow in normal p&tients is not clear. 
There is no evidence, however, that it does so 
by stimulating the few pre-existant stem cells 
to maturation. The sepsis of agranulocytosis 
is admitted by all to be the result (not the 
cause) of leukopenia. Those authors with wide 
experience in the disease have seen cases in 
which ttle peripheral white count has risen 
co-incidentally with the development of ab-
scesses. It does not follow that the abscess 
caused the hematological improvement. No one 
has suggested giving pyogenic organisms intra-
muscularly as a therapeutic agent. Many authors 
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report a white cell eleva~on coincidentally 
with the development of the outward and visible 
signs of sepsis and, ,if the peripheral blood 
be carefully followed, they report often, a 
sudden drop of leukocytes with abscess form-
ation and to be followed again, in a few hours 
or days, by a prompt rise to the previous level 
or even higher level. According to Jackson and 
Parker (33) the bacteria have been present all 
along, but no white cells have been available. 
"Laudable" pus could not be formed; no "abscess" 
could develop. The return of bone marrow ac-
tivity supplies these white cells and they have 
been immediately drawn to the sight of infection, 
thus temporarily depleting the supply in the per-
ipheral circulation. Hence the transient fall 
in peripheral white count. Further investigat-
ion in this aspect of the disease reveals that 
agranulocytosis has developed, in the presence of 
pre-~xisting and patent sepsis. Millmann and 
Furculo's (38) patient "was stricken in her sec-
ond attack during a time when she was suffering 
from two abscesses in the gluteal region". This. 
.-
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would tend to indicate that in thi~ case, at 
least, abscess formation which has been advo-
cated as a method of treatment of agranulocytosis 
was of no benefit. Therefore, in this review of 
the literature, the evidence that sepsis and ne-
crosis in cases of agranulocytosis bring about 
a regeneration of the marrowE not convincing. 
Liver extract has been advocated by Foran 
(45). He injected the equivalent of one hundred 
grams of liver into the vein or muscle every eight 
to twelve hours until a definite rise of total 
whitecpunt had taken place. Four cases apparent-
ly true agranulocytosis were successfully tre.ated. 
Coggeshall (46) injected six vials of liver ex-
tract (Lilly 343) intravenously each day. His 
cases failed to respond. Silver (29) treated a 
case of agranulocytosis due to dinitrophenol with 
liver without beneficial results. Bonsdorff (47) 
treated two cases with liver intravenously with 
recovery in both instances. However, his first 
case was evidently pernicious anemia. She had 
a red count of 528,00 per c.mm., a color index 
of 1 .. 32 and a white count of 1,750. His second 
patient had extreme leukopenia, apparently due 
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to novarsenobenzol and bismuth.. The withdrawal 
of these drugs may well have had as beneficial 
an effect as liver extract. Bonsdorff (47) im-
plies that because the white ce~l count rises 
in pernicious anemia following liver therapy, 
it should rise in agranulocytosis. Yet the mech-
anism of leukopenia in pernicious anemia is not 
known. It may be that it is similar to that 
which produces the anemia in leukemia, mmely a 
crowding out of one series of cells by an over-
growth of another. If this is so , liver thE~rapy 
would raise the white count in pernicious anemia 
by an indirect rather than by a direct method. 
Therefore, summing up this phase of the treat-
ment, we may say-that spme few cases have been 
successfully treated with liver extract, but 
the ultimate value of this drug at the present 
time cannot be estimated. 
In 1930 Reznikoff (48)< advocated the use 
of adenine sulphate (one of the breakdown pro-
ducts of Pentnucleotide) in the treatment of 
agranulocytosis and in 1933 Reznikoff (49) sum-
marized the results in fifteen cases with eleven 
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recoveries. He also treated eight cases in which 
the diagnosis was doubtful with but one recovery 
and twelve cases complicating other diseases with 
two recoveries, and these were temporary. His 
conclusionsin so far as pure agranulocytosis were 
concerned were conservatively optomistic. 
In 1924 Jackson (50) definitely demonstrated 
the presence of pentose nucleotide in normal hu-
man blood. In as much as it has been shown by 
Doan, Zerfas, Warren, and Ames (51)· in 1928, that 
such products could raise the peripheral white 
count in normal animals, Jackson (52) decided to 
try the effects of this substance, presumably a 
normal metabolite of the intact and healthy or-
ganizm, in those conditions characterized by ex-
treme leukopenia. 
In 1931 he (52) reported the res·,~lts of 
such therapy in twenty cases of extreme leu-
kopenia or neutropenia with fourteen recoveries. 
In 1932 Jackson and Barker (53) reported an an-
alysis of sixty-nine case~ including the original 
twenty. In the tdal series the mortality Was 
only twenty-six percent •. 
32. 
Pentnucleotide (N.N.R.) may be given intra-
muscularly or intravenously. In the average case 
of' agranulocytosis v'li tll a white count between 
1,000 and 2,000 per c.mm., 10 cc. of Pentmcleotide 
are given intramuscularly two or preferably, three 
times a day until the white count has definitely 
risen and young neutrophils have appea,red. This 
change usually occurES on or about the fifth day 
of treatment. 10 cc. are then given once a day 
until the white count has been normal for several 
days. Most authors advocate in those patients 
who are extremely sick and especially in those 
in which the total white count is below 1,000 
40 cc. should be given a day until the white count 
has definitely risen and young neutrophils have 
appeared. 
tageously. 
50 cc. may be given even more advan-
The drug may also be administered 
intravenously well diluted in saline by the con-
tinuous drip method, the speed of injection by 
such that no untoward reactions occurr. Usually 
fifty to Qne hundred drops may be given a min-
ute when 20 cc. of pentnucleotide are diluted in 
1,000 cc. of normal saline solution. The drug 
should be continued in large doses until the 
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white count has definitely risen and in some-
what smaller amounts until it h~s been normal 
for several days, further therapy with pent-
nucleotide is useless, (53). 
Usually there are no untoward reactions 
of the patient to the drug. In some there is 
a transient sense 'of discomfort at the sight 
of the-injection. In others, there may be pre-
cordial distress, dyspenea or nausea. Rarely 
are the symptoms alarming. If, however, they 
are sufficiently severeto upset the patient the 
individual dose may be reduced and the number of 
injections per day correspondingly increased. 
In this manner one can almost always give the re-
quired amount each day. It is useless, especially 
in severe cases, to give small doses. The drug 
should never be given to a patient with an ana-
phalactic history, nor to one with severe cardiac 
damage. 
Doan (37) states that in fC'!vorable cases the 
first signs of improvement following pentnucleotide 
therapy are evidenced by the appearance of myelocytes 
in the blood stream. These cells may reach twenty 
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percent of the total white cells. According 
to most observers, this change usually occurs 
on or about the fourth day of therapy and cor-
responds in certain measure to the reticulocyte 
rise in pernicious anemia. Shortly thereafter, 
the temperature falls, the total white count rises 
and more mature neutrophils take the place of the 
immoture cells. 
In one series of one hundred and three pat-
ients reported that were treate~ in this way sixty-
nine or sixty-seven percent recovered and are still 
alive (58). Four additional patients recovered 
from their initial attack but died in a subsequent 
relapse. Thus the mortality (thirty-three percent 
for the entire series) is considerably lower than 
that generally accepted for the untreated disease, 
and considerably lower than that for any comparable 
series treated by any other measures. Taussig and 
Schnoebelen (45), in three hundred and thirty col-
lected cases give a mortality of seventy-six per-
c~nt, and furthermore, they scored a recovery for 
each and every remission. The corrected mortal-
ity in their series would naturally be consider-
ably higher. Brogsitter (2) in 1930 found a mor-
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tality of seventy-seven percent in sixty-four 
cases. Fuld (54) in 1930 noted recovery in 
but twenty-three cases out of two hundred and 
forty-eight. A mortality of ninety-one percent. 
Uffenorde (40) found a mortality rate of seventy-
seven percent in 1934. In 1934 Roberts and 
Kracke (39) stated "complete granulopenia is us-
ually a fatal disease during the first or a lat-
er attack", and these authors say that they 
have not seen any of their recovered cases re-
turn to complete health. Rosenthal (55) re-
ports ten cases with five recoveries. 
Pentnucleotide (NNR) has been used with 
apparent success by many, (8), (9), (10), (2'6), 
(27), (38), (41), (56), (57), (58), (59), (60), 
(61), (62), and (63). 
Zia and Fory~er (64) have used it with con-
siderable success in cases of agranulocytosis, 
complicating Kala~azar. They say, "It would 
appear that the administration of pentose nuo-
leotide or purine basis offers by far the most 
satisfactory treatment, not only for agranulo-
cytosis but also for the conditions of agran-
ulocytosis, the result of pyogenic infection 
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or of. chronic benzene poisoning". 
Others have had less success, (47), (65), 
and (66). In not all of these cases was the 
diagnosis true agranulocytosis. 
It is impossible at present to evaluate 
properly the true usefullness of the drug. It 
appears to be harmless, even over long periods 
of time. The mortality of those cases treated 
with it, seems to be definitely ·loweredcthan 
that in any comparable senes treated by any 
other means. Certain confirmatory evidence is 
brought forward by the extramudullary ~yelopoiesis 
which may be brought about by its injection into 
animals and the uniformity with which hematolog-
ical improvement occurs about the fifth day of 
treatment. The possibility of spontaneous re-
mission must, however, always be born in mind 
and any individual case cannot be easily dis-
missed. Patients have received the drug in ad-
equate amounts and recovered only to relapse 
again with complete therapeutic failure on the 
second attempt,.(65). Patients have received 
the drug and failed to respond and then recovered 
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spontaneously, (57). However, the fact remains 
that no other therapeutic agent has been shown 
to be more efficient. 
Zinniger (66) quoted above as being unen-
thusiastic about Pentnucleotlde, used liver, 
iron, leukocytic extract, sodium nucleinate, ad-
enine sulphate, and guanine with indi.fferent re-
sults. Silver (29) reports a patient with twenty 
percent neutrophils and ten percent monocytes that 
died in spite of liver extract iherL'py. Zinninger t s 
(66) patient, who failed m respond to pentneucleo-
tide; died two months later, havi.ng just "responded" 
to Addisin. 
At present, it would seem that pentneucleotide, 
provided there are no untoward reactions,offers 
the best chance of recovery in a patient with agran-
ulocytosis. 
It stands to reason that intelligent bedside 
care, careful nursing, adequate nourishij1ent, and 
fluids are all a necessary and.obvious part of the 
treatment. The patient must be protected in so 
far as possible from infection, but to attempt to 
sterilize the ulcerated lesions.by·means of . 
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antiseptics is fruitless. Such constant ther-
apeutic nudging serves only to keep the pa.tient 
awake when he should be resting, but frequent 
washings of the mouth and throat with soothing 
solutions may allay the pain, reduce the amount 
of secretion and make the patient in general 
more comfortable. 
It h2.s been suggested by Beck (15), Rob-
erts and Kracke (39), that surgical interven-
tion is contraindicated. However, in this re-
view, I would say that most authors disagree 
and believe that such surgery should be under-
taken as would be advised in a patient with 
normal blood. 
It is certain that all drugs containing 
a benzene ring shoull be immediately and com-
pletely omitted. Madison and Squier (20) found 
one hundred percent in their six cases which 
continued to take amidopyrine or its allies. 
In certain instances, edema of the throat 
may be so great that deglutition and even res-
piration may be difficult or impossible, Trach-
eotomy has been tried in such instances, but I 
believe most authors consider it of no avail. 
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SUMMARY 
1. Whether agranulocytosis is to be regarded 
as a disease entity or a syndrome cannot as yet 
be dogmatically stated, but it is probsbl? that 
such a disease entity does exist. 
2. The etiology of the condition must for 
the present, remain uncertain. Amidopyrine and 
its allies, however, may and probably do have 
much to do with the development of certain cases. 
3. The pathological changes in the bone mar-
row of agranulocytosis consist of a maturation . 
arrest at the stem cell stage. Later in the course 
of the disease plasma cells and lymphocytes re-
placed, to a large extent, the previously existing 
stem cells. 
4. Careful nursing and asepsis and intel-
ligent general care of the patient are obviously 
essential and important parts of the treatment. 
5. Pentneucl.eotide (NNR) intramuscularly or 
intravenously offers, at the present time; the best 
method of stimulating the bone marrow to recovery 
and the results following this therapy have been 
more satisfactory than those after any other type 
of treatment. 
-40. 
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